Evidence map›Paper›PMID 42852430›Full record

ArticleCureus2026

Skin Metastasis of an Occult Primary Bronchopulmonary Disease: A Case Report and Literature Review.

Hadil Rafi, Soufiane Berhili, Ahmed BenSghier, Mohamed Moukhlissi, Loubna Mezouar

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hadil RafiRadiotherapy, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR.
Soufiane BerhiliRadiation Oncology, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, MAR.
Ahmed BenSghierRadiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR.
Mohamed MoukhlissiRadiotherapy, Mohammed VI University Hospital, Oujda, MAR.
Loubna MezouarRadiation Oncology, Centre Hospitalier Universitaire Mohammed VI, Oujda, MAR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous metastases of pulmonary origin are rare but clinically significant, typically indicating advanced disease with a poor prognosis. They may occasionally reveal an occult lung cancer, as illustrated by the case reported here. We report the case of a 78-year-old man, a former heavy smoker, who presented with a rapidly growing, ulcerated, exophytic nodule on the anterior chest wall. Skin biopsy revealed a poorly differentiated adenocarcinoma, with negative thyroid transcription factor-1 (TTF-1) and Napsin A staining, raising diagnostic difficulty regarding the primary origin. Chest CT subsequently identified a 4.1 cm tumor of the right lower lobe, and bronchoscopic biopsy confirmed a bronchial adenocarcinoma. Staging revealed disseminated disease (cT2b cN1 cM1c, Stage IVB) with cerebral, adrenal, and bone metastases. A multidisciplinary tumor board recommended whole-brain radiotherapy (30 Gy in 10 fractions) combined with palliative chemotherapy (cisplatin-gemcitabine), with stable disease observed at six months of follow-up. This case underlines the limitations of TTF-1 and Napsin A negativity in excluding a pulmonary origin, particularly in poorly differentiated tumors, and highlights the value of an integrated clinical, radiological, morphological, and immunohistochemical approach. Management of extensively disseminated disease remains essentially palliative; surgery has no impact on survival and is reserved for palliative or diagnostic indications.

Indexed as

cutaneous metastasisimmunohistochemistrylung adenocarcinomanapsin aoccult primary tumorpalliative chemotherapyttf-1whole-brain radiotherapy

Identifiers

PMID42852430
PMCPMC13649164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.